A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called ThymoglobulinÂ® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)